- Home
- TAK vs ABEV Comparison
TAK vs ABEV Comparison
Compare TAK & ABEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- ABEV
- Stock Information
- Founded
- TAK 1781
- ABEV 1885
- Country
- TAK Japan
- ABEV Brazil
- Employees
- TAK N/A
- ABEV N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- ABEV Beverages (Production/Distribution)
- Sector
- TAK Health Care
- ABEV Consumer Staples
- Exchange
- TAK Nasdaq
- ABEV Nasdaq
- Market Cap
- TAK 41.1B
- ABEV 36.2B
- IPO Year
- TAK N/A
- ABEV N/A
- Fundamental
- Price
- TAK $12.94
- ABEV $1.79
- Analyst Decision
- TAK
- ABEV Hold
- Analyst Count
- TAK 0
- ABEV 1
- Target Price
- TAK N/A
- ABEV $2.50
- AVG Volume (30 Days)
- TAK 1.8M
- ABEV 45.3M
- Earning Date
- TAK 01-30-2025
- ABEV 02-27-2025
- Dividend Yield
- TAK 4.90%
- ABEV 6.25%
- EPS Growth
- TAK 49.73
- ABEV N/A
- EPS
- TAK 1.27
- ABEV 0.16
- Revenue
- TAK $31,732,209,416.00
- ABEV $15,133,784,839.00
- Revenue This Year
- TAK $6.15
- ABEV $12.22
- Revenue Next Year
- TAK $0.86
- ABEV $5.55
- P/E Ratio
- TAK $20.23
- ABEV $11.27
- Revenue Growth
- TAK 9.43
- ABEV N/A
- 52 Week Low
- TAK $12.58
- ABEV $1.76
- 52 Week High
- TAK $15.08
- ABEV $2.72
- Technical
- Relative Strength Index (RSI)
- TAK 36.92
- ABEV 35.00
- Support Level
- TAK $12.86
- ABEV $1.77
- Resistance Level
- TAK $13.20
- ABEV $1.86
- Average True Range (ATR)
- TAK 0.13
- ABEV 0.05
- MACD
- TAK -0.01
- ABEV 0.01
- Stochastic Oscillator
- TAK 12.71
- ABEV 18.33
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving Interbrew (now AB InBev) a controlling interest of 61.8% as at the end of 2023.